Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Elife ; 112022 02 14.
Artigo em Inglês | MEDLINE | ID: mdl-35156922

RESUMO

Although cerebellar alterations have been implicated in stress symptoms, the exact contribution of the cerebellum to stress symptoms remains to be elucidated. Here, we demonstrated the crucial role of cerebellar neurons projecting to the ventral tegmental area (VTA) in the development of chronic stress-induced behavioral alterations in mice. Chronic chemogenetic activation of inhibitory Purkinje cells in crus I suppressed c-Fos expression in the DN and an increase in immobility in the tail suspension test or forced swimming test, which were triggered by chronic stress application. The combination of adeno-associated virus-based circuit mapping and electrophysiological recording identified network connections from crus I to the VTA via the dentate nucleus (DN) of the deep cerebellar nuclei. Furthermore, chronic inhibition of specific neurons in the DN that project to the VTA prevented stressed mice from showing such depression-like behavior, whereas chronic activation of these neurons alone triggered behavioral changes that were comparable with the depression-like behaviors triggered by chronic stress application. Our results indicate that the VTA-projecting cerebellar neurons proactively regulate the development of depression-like behavior, raising the possibility that cerebellum may be an effective target for the prevention of depressive disorders in human.


Assuntos
Cerebelo/citologia , Depressão , Neurônios/metabolismo , Estresse Fisiológico , Área Tegmentar Ventral/fisiologia , Animais , Comportamento Animal , Feminino , Interneurônios/metabolismo , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Endogâmicos ICR
2.
Neuropharmacology ; 128: 282-292, 2018 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-29079294

RESUMO

Amyloid ß (Aß) is a key mediator for synaptic dysfunction and cognitive impairment implicated in Alzheimer's disease (AD). However, the precise mechanism of the toxic effect of Aß is still not completely understood. Moreover, there is currently no treatment for AD. Protein kinase B (PKB, also termed Akt) is known to be aberrantly regulated in the AD brain. However, its potential function as a therapeutic target for AD-associated memory impairment has not been studied. Here, we examined the role of a direct Akt activator, SC79, in hippocampus-dependent memory impairments using Aß-injected as well as 5XFAD AD model mice. Oligomeric Aß injections into the 3rd ventricle caused concentration-dependent and time-dependent impairments in learning/memory and synaptic plasticity. Moreover, Aß aberrantly regulated caspase-3, GSK-3ß, and Akt signaling, which interact with each other in the hippocampus. Caspase-3 and GSK-3ß inhibitor ameliorated memory impairments and synaptic deficits in Aß-injected AD model mice. We also found that pharmacological activation of Akt rescued memory impairments and aberrant synaptic plasticity in both Aß-treated and 5XFAD mice. These results suggest that Akt could be a therapeutic target for memory impairment observed in AD.


Assuntos
Acetatos/uso terapêutico , Doença de Alzheimer/complicações , Benzopiranos/uso terapêutico , Transtornos da Memória/tratamento farmacológico , Transtornos da Memória/etiologia , Plasticidade Neuronal/efeitos dos fármacos , Proteína Oncogênica v-akt/metabolismo , Doença de Alzheimer/genética , Peptídeos beta-Amiloides/administração & dosagem , Animais , Aprendizagem da Esquiva/efeitos dos fármacos , Benzofuranos/farmacologia , Modelos Animais de Doenças , Inibidores Enzimáticos/uso terapêutico , Potenciais Evocados/efeitos dos fármacos , Potenciais Evocados/fisiologia , Regulação da Expressão Gênica/efeitos dos fármacos , Regulação da Expressão Gênica/genética , Hipocampo/efeitos dos fármacos , Hipocampo/patologia , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Transgênicos , Plasticidade Neuronal/genética , Oligopeptídeos/farmacologia , Oxidiazóis/farmacologia , Fragmentos de Peptídeos/administração & dosagem , Tempo de Reação/efeitos dos fármacos , Tempo de Reação/genética , Reconhecimento Psicológico/efeitos dos fármacos
3.
Sci Rep ; 6: 29152, 2016 07 05.
Artigo em Inglês | MEDLINE | ID: mdl-27377368

RESUMO

Mouse models of Alzheimer's disease (AD) have been developed to study the pathophysiology of amyloid ß protein (Aß) toxicity, which is thought to cause severe clinical symptoms such as memory impairment in AD patients. However, inconsistencies exist between studies using these animal models, specifically in terms of the effects on synaptic plasticity, a major cellular model of learning and memory. Whereas some studies find impairments in plasticity in these models, others do not. We show that long-term potentiation (LTP), in the CA1 region of hippocampal slices from this mouse, is impared at Tg2576 adult 6-7 months old. However, LTP is inducible again in slices taken from Tg2576 aged 14-19 months old. In the aged Tg2576, we found that the percentage of parvalbumin (PV)-expressing interneurons in hippocampal CA1-3 region is significantly decreased, and LTP inhibition or reversal mediated by NRG1/ErbB signaling, which requires ErbB4 receptors in PV interneurons, is impaired. Inhibition of ErbB receptor kinase in adult Tg2576 restores LTP but impairs depotentiation as shown in aged Tg2576. Our study suggests that hippocampal LTP reemerges in aged Tg2576. However, this reemerged LTP is an insuppressible form due to impaired NRG1/ErbB signaling, possibly through the loss of PV interneurons.


Assuntos
Envelhecimento/patologia , Doença de Alzheimer/fisiopatologia , Potenciação de Longa Duração/fisiologia , Doença de Alzheimer/complicações , Doença de Alzheimer/patologia , Animais , Modelos Animais de Doenças , Receptores ErbB/metabolismo , Hipocampo/patologia , Hipocampo/fisiopatologia , Humanos , Interneurônios/metabolismo , Masculino , Transtornos da Memória/complicações , Transtornos da Memória/fisiopatologia , Camundongos Transgênicos , Neuregulina-1/metabolismo , Plasticidade Neuronal , Parvalbuminas/metabolismo , Reconhecimento Psicológico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA